CLINICAL ROLE -
Medical professionals share insights on treatment considerations and patient selection for bispecific antibody therapy and the process for referring patients to other institutions for care.
Phase 3 DREAMM-8 Trial Data Show Superior Efficacy of BPd vs PVd in Relapsed/Refractory Multiple Myeloma
Pharmacy Focus: Oncology Edition - Consider Treatment Sequences Carefully in Myeloma
Quadruple Therapies Including Immunotherapy Agents Show Benefit in Multiple Myeloma
Biological Therapies for Cancer
Sixteen Researchers from Florida Cancer Specialists & Research Institute Share Cancer Care Discoveries at 2024 ASCO® Annual Meeting
FDA Accepts Isatuximab for Priority Review for Treatment of Transplant-Ineligible Multiple Myeloma